ArticleAsian Pacific journal of cancer prevention : APJCP2025
Incidence, Trends and Survival of Oral Cavity Squamous Cell Carcinoma in Aotearoa New Zealand over 15 Years (2006-2020).
Article in Asian Pacific journal of cancer prevention : APJCP, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Heterogeneity in Survival Over Time by Age, Sex, and Subsite in Early-Onset Oral Cavity Cancer.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOver recent decades, there have been changes in the incidence of squamous cell carcinoma of the oral cavity (OCSCC) in many countries. However, recent data on OCSCC in New Zealand has not been examined. This study examines the current incidence, trends and survival of OCSCC in New Zealand and identifies demographic differences by age, sex and ethnicity.
methodPatients with a primary diagnosis of OCSCC between 2006 and 2020 were retrieved from the National Cancer Registry. Age-standardised incidence rates (ASRs) were calculated and compared using age-standardised incidence rate ratios (ASRRs). Time trends were assessed by joinpoint regression with annual percentage changes, and overall and relative survival rates were estimated.
resultsOver 15 years, 2094 cases of OCSCC were identified, and the average annual incidence was 2.1 per 100,000. The rates were higher in males (ASRR= 1.4 compared to females), older age groups (ASRR=11.3 in 50-69 years; ASRR=25.4 in 70+ years compared to <50 years), and Pasifika (ASRR=1.4, compared to European). OCSCC incidence increased significantly between 2009 and 2017 and decreased between 2017 and 2020. Females followed the same pattern of trends as overall OCSCC, while trends in males showed no significant changes. The survival outcome of OCSCC at five years was 57% and 66% for absolute and relative survival, respectively. Survival outcomes were poorer in males (HR = 1.20 compared to females), older age groups (HR=1.77 in 50-69 years; HR=4.21 in 70+ years compared to <50 years), Māori (HR=1.37 compared to European) and tumours originated from the floor of mouth (HR=1.40), palate (HR=1.47) and buccal (HR=1.54) compared to tongue.
conclusionThis study shows that the incidence of OCSCC overall and in females increased from 2009 to 2017, but declined significantly after 2017 in New Zealand. Incidence and survival rates are influenced by sex, age, ethnicity and subsite.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.